Pamella Nizio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pamella Nizio has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Lorra Garey
University of Houston
8 shared publications - Michael J. Zvolensky
Department of Psychology, University of Houston
8 shared publications - Brooke Kauffman
Department of Psychology, University of Houston
5 shared publications - Julia D. Buckner
Department of Psychology, Louisiana State University, Baton Rouge, USA
4 shared publications - Michael S. Businelle
University of Oklahoma Health Campus and Stephenson Cancer Center, OK, USA
4 shared publications - Ava A. Jones
University of Houston
3 shared publications
Latest Publications
- 11 May 2026
- Published by Taylor & Francis in Cognitive Behaviour Therapy
- p. 1-11
The indirect effect of anxiety sensitivity on smoking motives through false safety behaviors among Black adults who smoke
Black persons who smoke begin smoking later in life and smoke fewer cigarettes per day compared to White persons who smoke (Caraballo et al., 1998; Schoenborn et al., 2013). Despite smoking at lowe...
- 11 May 2026
- Published by Taylor & Francis in Cognitive Behaviour Therapy
- p. 1-11
The indirect effect of anxiety sensitivity on smoking motives through false safety behaviors among Black adults who smoke
Black persons who smoke begin smoking later in life and smoke fewer cigarettes per day compared to White persons who smoke (Caraballo et al., 1998; Schoenborn et al., 2013). Despite smoking at lowe...
- Open Access
- 19 February 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e52776
Mobile Intervention to Address Cannabis Use Disorder Among Black Adults: Protocol for a Randomized Controlled Trial
Background: African American or Black (hereafter referred to as Black) adults who use cannabis use it more frequently and are more likely to meet criteria for cannabis use disorder (CUD) than both White and Hispanic or Latin individuals. Black adults may be more apt to use cannabis to cope with distress, which constitutes a false safety behavior (FSB; a behavior designed to reduce psychological distress in the short term). Although FSB engagement can perpetuate the cycle of high rates of CUD among Black individuals, limited work has applied an FSB elimination treatment approach to Black adults with CUD, and no previous work has evaluated FSB reduction or elimination in the context of a culturally tailored and highly accessible treatment developed for Black individuals. Objective: This study aims to develop and pilot-test a culturally tailored adaptive intervention that integrates FSB reduction or elimination skills for cannabis reduction or cessation among Black adults with probable CUD (Culturally Tailored-Mobile Integrated Cannabis and Anxiety Reduction Treatment [CT-MICART]). Methods: Black adults with probable CUD (N=50) will complete a web-based screener, enrollment call, baseline assessment, 3 daily ecological momentary assessments (EMAs) for 6 weeks, and a follow-up self-report assessment and qualitative interview at 6 weeks after randomization. Participants will be randomized into 1 out of the 2 conditions after baseline assessment: (1) CT-MICART+EMAs for 6 weeks or (2) EMAs only for 6 weeks. Results: The enrollment started in June 2023 and ended in November 2023. Data analysis will be completed in March 2024. Conclusions: No culturally tailored, evidence-based treatment currently caters to the specific needs of Black individuals with CUD. This study will lay the foundation for a new approach to CUD treatment among Black adults that is easily accessible and has the potential to overcome barriers to treatment and reduce practitioner burden in order to support Black individuals who use cannabis with probable CUD. Trial Registration: ClinicalTrials.gov NCT05566730; https://clinicaltrials.gov/study/NCT05566730 International Registered Report Identifier (IRRID): DERR1-10.2196/52776
- 19 February 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e52776
Open AccessMobile Intervention to Address Cannabis Use Disorder Among Black Adults: Protocol for a Randomized Controlled Trial
Background: African American or Black (hereafter referred to as Black) adults who use cannabis use it more frequently and are more likely to meet criteria for cannabis use disorder (CUD) than both White and Hispanic or Latin individuals. Black adults may be more apt to use cannabis to cope with distress, which constitutes a false safety behavior (FSB; a behavior designed to reduce psychological distress in the short term). Although FSB engagement can perpetuate the cycle of high rates of CUD among Black individuals, limited work has applied an FSB elimination treatment approach to Black adults with CUD, and no previous work has evaluated FSB reduction or elimination in the context of a culturally tailored and highly accessible treatment developed for Black individuals. Objective: This study aims to develop and pilot-test a culturally tailored adaptive intervention that integrates FSB reduction or elimination skills for cannabis reduction or cessation among Black adults with probable CUD (Culturally Tailored-Mobile Integrated Cannabis and Anxiety Reduction Treatment [CT-MICART]). Methods: Black adults with probable CUD (N=50) will complete a web-based screener, enrollment call, baseline assessment, 3 daily ecological momentary assessments (EMAs) for 6 weeks, and a follow-up self-report assessment and qualitative interview at 6 weeks after randomization. Participants will be randomized into 1 out of the 2 conditions after baseline assessment: (1) CT-MICART+EMAs for 6 weeks or (2) EMAs only for 6 weeks. Results: The enrollment started in June 2023 and ended in November 2023. Data analysis will be completed in March 2024. Conclusions: No culturally tailored, evidence-based treatment currently caters to the specific needs of Black individuals with CUD. This study will lay the foundation for a new approach to CUD treatment among Black adults that is easily accessible and has the potential to overcome barriers to treatment and reduce practitioner burden in order to support Black individuals who use cannabis with probable CUD. Trial Registration: ClinicalTrials.gov NCT05566730; https://clinicaltrials.gov/study/NCT05566730 International Registered Report Identifier (IRRID): DERR1-10.2196/52776
- Open Access
- 14 September 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Mobile Intervention to Address Cannabis Use Disorder Among Black Adults: Protocol for a Randomized Controlled Trial (Preprint)
BACKGROUND African American or Black (hereafter referred to as Black) adults who use cannabis use it more frequently and are more likely to meet criteria for cannabis use disorder (CUD) than both White and Hispanic or Latin individuals. Black adults may be more apt to use cannabis to cope with distress, which constitutes a false safety behavior (FSB; a behavior designed to reduce psychological distress in the short term). Although FSB engagement can perpetuate the cycle of high rates of CUD among Black individuals, limited work has applied an FSB elimination treatment approach to Black adults with CUD, and no previous work has evaluated FSB reduction or elimination in the context of a culturally tailored and highly accessible treatment developed for Black individuals. OBJECTIVE This study aims to develop and pilot-test a culturally tailored adaptive intervention that integrates FSB reduction or elimination skills for cannabis reduction or cessation among Black adults with probable CUD (Culturally Tailored-Mobile Integrated Cannabis and Anxiety Reduction Treatment [CT-MICART]). METHODS Black adults with probable CUD (N=50) will complete a web-based screener, enrollment call, baseline assessment, 3 daily ecological momentary assessments (EMAs) for 6 weeks, and a follow-up self-report assessment and qualitative interview at 6 weeks after randomization. Participants will be randomized into 1 out of the 2 conditions after baseline assessment: (1) CT-MICART+EMAs for 6 weeks or (2) EMAs only for 6 weeks. RESULTS The enrollment started in June 2023 and ended in November 2023. Data analysis will be completed in March 2024. CONCLUSIONS No culturally tailored, evidence-based treatment currently caters to the specific needs of Black individuals with CUD. This study will lay the foundation for a new approach to CUD treatment among Black adults that is easily accessible and has the potential to overcome barriers to treatment and reduce practitioner burden in order to support Black individuals who use cannabis with probable CUD. CLINICALTRIAL ClinicalTrials.gov NCT05566730; https://clinicaltrials.gov/study/NCT05566730 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/52776
- 14 September 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessMobile Intervention to Address Cannabis Use Disorder Among Black Adults: Protocol for a Randomized Controlled Trial (Preprint)
BACKGROUND African American or Black (hereafter referred to as Black) adults who use cannabis use it more frequently and are more likely to meet criteria for cannabis use disorder (CUD) than both White and Hispanic or Latin individuals. Black adults may be more apt to use cannabis to cope with distress, which constitutes a false safety behavior (FSB; a behavior designed to reduce psychological distress in the short term). Although FSB engagement can perpetuate the cycle of high rates of CUD among Black individuals, limited work has applied an FSB elimination treatment approach to Black adults with CUD, and no previous work has evaluated FSB reduction or elimination in the context of a culturally tailored and highly accessible treatment developed for Black individuals. OBJECTIVE This study aims to develop and pilot-test a culturally tailored adaptive intervention that integrates FSB reduction or elimination skills for cannabis reduction or cessation among Black adults with probable CUD (Culturally Tailored-Mobile Integrated Cannabis and Anxiety Reduction Treatment [CT-MICART]). METHODS Black adults with probable CUD (N=50) will complete a web-based screener, enrollment call, baseline assessment, 3 daily ecological momentary assessments (EMAs) for 6 weeks, and a follow-up self-report assessment and qualitative interview at 6 weeks after randomization. Participants will be randomized into 1 out of the 2 conditions after baseline assessment: (1) CT-MICART+EMAs for 6 weeks or (2) EMAs only for 6 weeks. RESULTS The enrollment started in June 2023 and ended in November 2023. Data analysis will be completed in March 2024. CONCLUSIONS No culturally tailored, evidence-based treatment currently caters to the specific needs of Black individuals with CUD. This study will lay the foundation for a new approach to CUD treatment among Black adults that is easily accessible and has the potential to overcome barriers to treatment and reduce practitioner burden in order to support Black individuals who use cannabis with probable CUD. CLINICALTRIAL ClinicalTrials.gov NCT05566730; https://clinicaltrials.gov/study/NCT05566730 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/52776
- 9 March 2023
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 128, 107145
Study protocol for approach bias retraining for nicotine addiction among dual combustible and electronic cigarette users
- 9 March 2023
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 128, 107145
Study protocol for approach bias retraining for nicotine addiction among dual combustible and electronic cigarette users
- 17 December 2022
- Published by Elsevier in Addictive Behaviors
- Vol. 139, 107593
Anxiety sensitivity and reasons for smoking among Black smokers
- 17 December 2022
- Published by Elsevier in Addictive Behaviors
- Vol. 139, 107593
Anxiety sensitivity and reasons for smoking among Black smokers
- 5 October 2022
- Published by Taylor & Francis in Cognitive Behaviour Therapy
- Vol. 52 (2) , 75-90
Evaluating resilience in terms of COVID-19 related behavioral health among Latinx adults during the coronavirus pandemic
The mental and behavioral health burden resulting from COVID-19 has disproportionately affected the Latinx population. Yet, no work has investigated the influence of resilience as a protective factor against COVID-19 related consequences. The aim of the current study was to evaluate resilience in relation to COVID-19 related fear, anxiety symptoms, COVID-19 anxiety-related sleep disturbances, and depression among Latinx persons (178 Latinx persons [31.5% female, Mage = 34.1 years, SD = 8.2]). It was hypothesized that greater levels of resilience would be associated with lower levels of all COVID-19 related behavioral health outcomes above and beyond the variance accounted for by years living in the United States (U.S.), degree of COVID-19 exposure, sex, age, education, and COVID-19 related work and financial troubles and home-life distress. Results indicated that greater levels of resilience were associated with lower levels of COVID-19 related fear (ΔR2 = .06, p < .001), anxiety symptoms (ΔR2 = .03, p = .005), COVID-19 anxiety-related sleep disturbances (ΔR2 = .06, p < .001), and depression (ΔR2 = .04, p = .001). Overall, the present study is the first to document the potential importance of resilience in relation to common and clinically significant COVID-19 behavioral health problems among Latinx persons.
- 5 October 2022
- Published by Taylor & Francis in Cognitive Behaviour Therapy
- Vol. 52 (2) , 75-90
Evaluating resilience in terms of COVID-19 related behavioral health among Latinx adults during the coronavirus pandemic
The mental and behavioral health burden resulting from COVID-19 has disproportionately affected the Latinx population. Yet, no work has investigated the influence of resilience as a protective factor against COVID-19 related consequences. The aim of the current study was to evaluate resilience in relation to COVID-19 related fear, anxiety symptoms, COVID-19 anxiety-related sleep disturbances, and depression among Latinx persons (178 Latinx persons [31.5% female, Mage = 34.1 years, SD = 8.2]). It was hypothesized that greater levels of resilience would be associated with lower levels of all COVID-19 related behavioral health outcomes above and beyond the variance accounted for by years living in the United States (U.S.), degree of COVID-19 exposure, sex, age, education, and COVID-19 related work and financial troubles and home-life distress. Results indicated that greater levels of resilience were associated with lower levels of COVID-19 related fear (ΔR2 = .06, p < .001), anxiety symptoms (ΔR2 = .03, p = .005), COVID-19 anxiety-related sleep disturbances (ΔR2 = .06, p < .001), and depression (ΔR2 = .04, p = .001). Overall, the present study is the first to document the potential importance of resilience in relation to common and clinically significant COVID-19 behavioral health problems among Latinx persons.
- 13 July 2020
- Published by Taylor & Francis in Cognitive Behaviour Therapy
- Vol. 49 (6) , 486-500
Exploring positive expectancies and quit status among adult electronic cigarette users
Initial research on electronic cigarette (e-cigarette) use suggests differences exist in levels of use, beliefs, and cessation difficulties among users. However, little research has explored how these factors interact to confer worse e-cigarette outcomes. The current study examined the association between positive expectancies of e-cigarette use and e-cigarette processes among 544 (51.1% female; Mage = 35.4 years, SD = 10.12) adult e-cigarette users who had and had not attempted to quit e-cigarettes, a defining characteristic believed to distinguish those with and without greater e-cigarette quit difficulty. Results indicated that greater positive outcome expectancies of e-cigarette use were significantly related to increased perceived risks, benefits, and barriers to quitting. The strength of the associations was stronger for those who reported past quit attempts compared to those who never attempted quitting. Overall, the current study highlights the potentially important role that positive expectancies for e-cigarette use and quit attempt status play in e-cigarette processes. Findings suggest a possible need to contextualize positive expectancies for e-cigarette use within future e-cigarette cessation tactics and tailoring treatments based on quit attempt status.
- 13 July 2020
- Published by Taylor & Francis in Cognitive Behaviour Therapy
- Vol. 49 (6) , 486-500
Exploring positive expectancies and quit status among adult electronic cigarette users
Initial research on electronic cigarette (e-cigarette) use suggests differences exist in levels of use, beliefs, and cessation difficulties among users. However, little research has explored how these factors interact to confer worse e-cigarette outcomes. The current study examined the association between positive expectancies of e-cigarette use and e-cigarette processes among 544 (51.1% female; Mage = 35.4 years, SD = 10.12) adult e-cigarette users who had and had not attempted to quit e-cigarettes, a defining characteristic believed to distinguish those with and without greater e-cigarette quit difficulty. Results indicated that greater positive outcome expectancies of e-cigarette use were significantly related to increased perceived risks, benefits, and barriers to quitting. The strength of the associations was stronger for those who reported past quit attempts compared to those who never attempted quitting. Overall, the current study highlights the potentially important role that positive expectancies for e-cigarette use and quit attempt status play in e-cigarette processes. Findings suggest a possible need to contextualize positive expectancies for e-cigarette use within future e-cigarette cessation tactics and tailoring treatments based on quit attempt status.
- 11 March 2020
- Published by Wiley in The American Journal on Addictions
- Vol. 29 (4) , 287-294
The Effects of Cannabis Use: A Test Among Dual Electronic and Combustible Cigarette Users
Background and Objectives: Despite greater rates of cannabis use among those that smoke combustible cigarettes, it is currently unknown whether cannabis use is related to e‐cigarette dependence or maladaptive beliefs about combustible cigarettes. Therefore, the current study sought to identify whether adult dual users of combustible and e‐cigarettes (ie, dual users) who also used cannabis differed from dual users who did not use cannabis on e‐cigarette dependence severity, perceived barriers to quitting, and perception of risks and of benefits of e‐cigarettes.Methods: Participants were 414 current dual users (48.3% female, Mage = 35.1 years, SD = 10.0), 51% of whom were current cannabis users.Results: Dual users who reported current cannabis use evidenced more severe dependence on e‐cigarettes (ηp2 = 0.12), higher perceived barriers for quitting e‐cigarettes (ηp2 = 0.06), and greater perceived benefits (ηp2 = 0.03) as well as higher perception of risks (ηp2 = 0.03) for using e‐cigarettes. The results were evident after controlling for the variance associated with sex, age, education, income, and frequency of e‐cigarette use.Discussion and Conclusions: Overall, the current findings suggest cannabis may be an important type of substance use behavior that is relevant to e‐cigarette dependence and beliefs about use and quitting among adult dual users.Scientific Significance: The present data extend current understanding of dual users by contextualizing cannabis use within e‐cigarette and combustible cigarette use behaviors and highlight a potential substance use behavior that may be targetable in the framework of nicotine cessation. (Am J Addict 2020;00:00–00)
- 11 March 2020
- Published by Wiley in The American Journal on Addictions
- Vol. 29 (4) , 287-294
The Effects of Cannabis Use: A Test Among Dual Electronic and Combustible Cigarette Users
Background and Objectives: Despite greater rates of cannabis use among those that smoke combustible cigarettes, it is currently unknown whether cannabis use is related to e‐cigarette dependence or maladaptive beliefs about combustible cigarettes. Therefore, the current study sought to identify whether adult dual users of combustible and e‐cigarettes (ie, dual users) who also used cannabis differed from dual users who did not use cannabis on e‐cigarette dependence severity, perceived barriers to quitting, and perception of risks and of benefits of e‐cigarettes.Methods: Participants were 414 current dual users (48.3% female, Mage = 35.1 years, SD = 10.0), 51% of whom were current cannabis users.Results: Dual users who reported current cannabis use evidenced more severe dependence on e‐cigarettes (ηp2 = 0.12), higher perceived barriers for quitting e‐cigarettes (ηp2 = 0.06), and greater perceived benefits (ηp2 = 0.03) as well as higher perception of risks (ηp2 = 0.03) for using e‐cigarettes. The results were evident after controlling for the variance associated with sex, age, education, income, and frequency of e‐cigarette use.Discussion and Conclusions: Overall, the current findings suggest cannabis may be an important type of substance use behavior that is relevant to e‐cigarette dependence and beliefs about use and quitting among adult dual users.Scientific Significance: The present data extend current understanding of dual users by contextualizing cannabis use within e‐cigarette and combustible cigarette use behaviors and highlight a potential substance use behavior that may be targetable in the framework of nicotine cessation. (Am J Addict 2020;00:00–00)